Stone Summit Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stone Summit Wealth's AMGN Position: Q2 2026 in Review
Stone Summit Wealth reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $8.22K and leaving 2,275 shares worth $824K. The position accounts for 0.21% of the portfolio, ranked #77.
Stone Summit Wealth first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stone Summit Wealth held 2,275 shares of Amgen worth $824K as of Q2 2026.
- Stone Summit Wealth sold 24 Amgen shares in Q2 2026, an estimated $8.22K.
- Amgen made up 0.21% of Stone Summit Wealth's portfolio in Q2 2026, its #77 holding.
- Stone Summit Wealth first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stone Summit Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.